Advanced search
Publication Cover
Future Oncology Volume 19, 2023 - Issue 24
Submit an article Journal homepage
1,591
Views
0
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol

Larotrectinib versus historical standard of care in patients with infantile fibrosarcoma: protocol of EPI-VITRAKVI

Matthieu Carton1 Biometry Unit, Institut Curie,PSL Research University, Paris, 75005, FranceORCID Iconhttps://orcid.org/0000-0002-6793-3273View further author information
ORCID Icon,
Johanna Peña Del Castillo2 Klinikum der Landeshauptstadt Stuttgart gKAöR, Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie 5 (Pädiatrische Onkologie, Hämatologie,Immunologie), Stuttgart, 70174, GermanyView further author information
,
Jean-Baptiste Colin3 Bayer HealthCare SAS, Loos, 59120, FranceView further author information
,
Milena Kurtinecz4 Bayer U.S. LLC, Whippany, NJ 07981, USAView further author information
,
Marion Feuilly5 Bayer HealthCare SAS, La Garenne-Colombes, 92035, FranceView further author information
,
Gaëlle Pierron6 Genetic Somatic Unit, PSL Research University,Institut Curie, Paris, 75005, FranceView further author information
,
Pierre Arvis3 Bayer HealthCare SAS, Loos, 59120, FranceView further author information
,
Soumeya Khadidja Khadir3 Bayer HealthCare SAS, Loos, 59120, FranceView further author information
,
Monika Sparber-Sauer2 Klinikum der Landeshauptstadt Stuttgart gKAöR, Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie 5 (Pädiatrische Onkologie, Hämatologie,Immunologie), Stuttgart, 70174, Germany;7 Medizinische Fakultät der Universität Tübingen,Tübingen, 72076, GermanyView further author information
&
Daniel Orbach8 SIREDO Oncology Center (Care, Innovation & Research for Children & AYA with Cancer), PSL Research University,Institut Curie, Paris, 75005, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2520-139XView further author information
ORCID Icon show all
Pages 1645-1653 | Received 09 Feb 2023, Accepted 21 Mar 2023, Published online: 03 May 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.